MK-0822 is a newly developed bone-targeting dual action pro-drug for osteoporosis and bone metastasis. It is also an inhibitor of cathepsin K, an enzyme involved in bone resorption.
Molecular Weight:
525.56
CAS Number:
[603139-19-1]
* VAT and and shipping costs not included. Errors and price changes excepted
